pharmaceutical-investing Ironwood and Alnylam Enter US GI Disease Education and Promotional Agreement
pharmaceutical-investing Alnylam Completes Enrollment in ENVISION Phase 3 Study of Givosiran, an Investigational RNAi Therapeutic for the Treatment of Acute Hepatic Porphyrias
Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis
Homerun Resources Inc. Completes District Control Strategy with Purchase Agreement for 582 Hectares of Land and Surface Rights over Santa Maria Eterna High Purity Silica Sand District, in Belmonte, Bahia, Brazil
New Found Gold Continues to Confirm Continuity of At-Surface High-Grade Gold at Keats Zone, Queensway Gold Project
